Encysive Pharmaceuticals Inc is a business in New York City, NY.
Name: | Encysive Pharmaceuticals Inc |
Business Address: | 50 Pequot Avenue, New York City, NY 10017 |
Phone Number: | (212) 733-2323 |
Contact Name: | Bruce D Given |
Business Category: | |
NAICS Code: | 325412 |
SIC Code: | 2834 |
Business Type: | B2B & B2C |
Employee Count: | 1 to 4 |
Location Type: | Headquarters |
Annual Revenue ($): | $50.000.000 to $99.999.999 |
Share This Business: | |
Related Businesses: |
Pfizer Inc - New York City, NY 10017 Pfizer Inc - New York City, NY 10017 Pfizer H C P Corporation - New York City, NY 10017 Angio Genex Inc - New York City, NY 10017 Kbl Healthcare Lp - New York City, NY 10017 Retrophin LLC - New York City, NY 10017 Aquavit Pharmaceuticals Inc - New York City, NY 10017 Denco Asset LLC - New York City, NY 10017 Esteve Usa Inc - New York City, NY 10017 |
Encysive Pharmaceuticals Inc started in the year and is categorized under . Bruce D Given makes sure they only deliver high quality merchandise, superior than most of its competitors.
Manned by 1 to 4 and fast-growing equally competitive individuals, at a strategically located Headquarters, Encysive Pharmaceuticals Inc supplies full line of products that are carefully planned and manufactured before they reach its customers.
Their physical company can be found in 50 Pequot Avenue, New York City, NY 10017. You can also navigate using these coordinates - 41.340106,-72.098989. Annual sales are continuously strong at $50.000.000 to $99.999.999. Their service-oriented approach keeps them on top of their BOTH market and sub-markets , and they remain up to date with current marketing trends.
Assigned SIC code is 2834, and NAICS code is 325412. You can visit the site at to check their full listing, ask support or refunds.
You can create your own account for better communication. Reliable sales personnel and maintenance support will be there to assist you. Any queries will also be handled by contacting (212) 733-2323. Contact numbers are available during business hours.